메뉴 건너뛰기




Volumn 25, Issue 1, 2015, Pages 141-143

Birth year distribution in reported hepatitis C cases in Switzerland

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; COHORT ANALYSIS; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; SWITZERLAND; VERY ELDERLY; YOUNG ADULT;

EID: 84922431625     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/cku095     Document Type: Article
Times cited : (10)

References (10)
  • 1
    • 58949093626 scopus 로고    scopus 로고
    • Chronic viral hepatitis as a public health issue in the world
    • Lavanchy D. Chronic viral hepatitis as a public health issue in the world. Best Pract Res Clin Gastroenterol 2008;22:991-1008.
    • (2008) Best Pract Res Clin Gastroenterol , vol.22 , pp. 991-1008
    • Lavanchy, D.1
  • 2
    • 84904720839 scopus 로고    scopus 로고
    • Historical epidemiology of hepatitis C virus (HCV) in selected countries
    • Bruggmann P, Berg T, Ovrehus AL, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014;21:5-33.
    • (2014) J Viral Hepat , vol.21 , pp. 5-33
    • Bruggmann, P.1    Berg, T.2    Ovrehus, A.L.3
  • 3
    • 50549092907 scopus 로고    scopus 로고
    • Market uptake of new antiviral drugs for the treatment of hepatitis C
    • Lettmeier B, Muhlberger N, Schwarzer R, et al. Market uptake of new antiviral drugs for the treatment of hepatitis C. J Hepatol 2008;49:528-36.
    • (2008) J Hepatol , vol.49 , pp. 528-536
    • Lettmeier, B.1    Muhlberger, N.2    Schwarzer, R.3
  • 4
    • 84902136664 scopus 로고    scopus 로고
    • The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
    • Razavi H, Waked I, Sarrazin C, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014;21:34-59.
    • (2014) J Viral Hepat , vol.21 , pp. 34-59
    • Razavi, H.1    Waked, I.2    Sarrazin, C.3
  • 5
    • 79960440620 scopus 로고    scopus 로고
    • European Centre for Disease Prevention and Control Stockholm 30 June 2014, date last accessed
    • European Centre for Disease Prevention and Control. Hepatitis B and C in the EU Neighbourhood: Prevalence, Burden of Disease and Screening Policies. Stockholm, 2010. http://ecdc.europa.eu/en/publications/Publications/TER-100914-Hep-B- C%20-EU-neighbourhood.pdf (30 June 2014, date last accessed).
    • (2010) Hepatitis B and C in the EU Neighbourhood: Prevalence, Burden of Disease and Screening Policies
  • 7
    • 84878398161 scopus 로고    scopus 로고
    • Hepatitis B and C in Switzerland-healthcare provider initiated testing for chronic hepatitis B and C infection
    • Fretz R, Negro F, Bruggmann P, et al. Hepatitis B and C in Switzerland-healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss Med Wkly 2013;143:w13793.
    • (2013) Swiss Med Wkly , vol.143 , pp. w13793
    • Fretz, R.1    Negro, F.2    Bruggmann, P.3
  • 8
    • 84867288022 scopus 로고    scopus 로고
    • Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965
    • Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012;61:1-32.
    • (2012) MMWR Recomm Rep , vol.61 , pp. 1-32
    • Smith, B.D.1    Morgan, R.L.2    Beckett, G.A.3
  • 9
    • 34548577147 scopus 로고    scopus 로고
    • Cohort Profile: The Swiss Hepatitis C Cohort Study (SCCS)
    • Prasad L, Spicher VM, Zwahlen M, et al. Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS). Int J Epidemiol 2007;36:731-7.
    • (2007) Int J Epidemiol , vol.36 , pp. 731-737
    • Prasad, L.1    Spicher, V.M.2    Zwahlen, M.3
  • 10
    • 84875287973 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States
    • Liu S, Cipriano LE, Holodniy M, Goldhaber-Fiebert JD. Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States. PLoS One 2013;8:e58975.
    • (2013) PLoS One , vol.8 , pp. e58975
    • Liu, S.1    Cipriano, L.E.2    Holodniy, M.3    Goldhaber-Fiebert, J.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.